Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depression

Author： Rickels Karl   Athanasiou Maria   Reed Carol  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.6, Iss.2, 2009-03, pp. : 217-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid‐onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 2, 2015-04 ,pp. : 125-130

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is sertraline plus transcranial direct current stimulation the future of effective depression treatment?

By Shiozawa Pedro   Cordeiro Quirino   Fregni Felipe   Brunoni Andre Russowsky  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 3, 2013-05 ,pp. : 213-215

Future Medicine

Access to resources Recommend Favorite

Tapping the potential of quantum dots for personalized oncology: current status and future perspectives

By Chen Chuang   Peng Jun   Sun Sheng-Rong   Peng Chun-Wei   Li Yan   Pang Dai-Wen  

Nanomedicine, Vol. 7, Iss. 3, 2012-03 ,pp. : 411-428

Future Medicine

Access to resources Recommend Favorite

Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases

By  

Current Signal Transduction Therapy, Vol. 3, Iss. 2, 2008-05 ,pp. : 138-151

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of pediatric lymphoma in Japan: Current status and plans for the future

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 4, 2015-08 ,pp. : 523-534

John Wiley & Sons Inc

Access to resources Recommend Favorite